$RXRX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in RECURSION PHARMACEUTICALS, INC..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in RECURSION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in RECURSION PHARMACEUTICALS, INC. for free.

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Virani Shafique	Chief Corp. Dev. Of ...	Option Exercise	C	2.22	732,000	1,625,040	732,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Virani Shafique	Chief Corp. Dev. Of ...	Option Exercise	C	2.22	732,000	1,625,040	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Virani Shafique	Chief Corp. Dev. Of ...	Buy	J	0.00	18,000	0	18,000	0 to 18 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Virani Shafique	Chief Corp. Dev. Of ...	Sell	J	0.00	18,000	0	0	18 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Option Exercise	C	2.22	1,500,000	3,330,000	1,500,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Option Exercise	C	2.22	820,313	1,821,095	820,313
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Option Exercise	C	2.22	1,500,000	3,330,000	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Option Exercise	C	2.22	820,313	1,821,095	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Option Exercise	C	0.00	149,077	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Buy	J	0.00	528,762	0	528,762	0 to 528.8 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Sell	J	0.00	528,762	0	0	528.8 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Secora Michael	Chief Financial Off ...	Buy	C	0.00	149,077	0	528,762	379.7 K to 528.8 K (+39.26 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Option Exercise	C	0.00	32,685	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Option Exercise	C	0.00	22,698	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Option Exercise	C	18.00	27,778	500,004	27,778
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Option Exercise	C	18.00	27,778	500,004	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Buy	J	0.00	13,889	0	596,390	582.5 K to 596.4 K (+2.38 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Sell	J	0.00	13,889	0	0	13.9 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Buy	J	0.00	582,501	0	582,501	0 to 582.5 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Sell	J	0.00	582,501	0	0	582.5 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Buy	J	0.00	1,350,000	0	1,350,000	0 to 1.4 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Sell	J	0.00	1,350,000	0	0	1.4 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Buy	J	0.00	450,000	0	450,000	0 to 450 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Sell	J	0.00	450,000	0	0	450 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Buy	J	0.00	1,422,048	0	1,422,048	0 to 1.4 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Sell	J	0.00	1,422,048	0	0	1.4 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Buy	C	0.00	55,383	0	1,422,048	1.4 M to 1.4 M (+4.05 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Larson Tina Marriott	President and COO	Option Exercise	C	2.47	150,000	370,500	150,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Larson Tina Marriott	President and COO	Option Exercise	C	1.06	712,500	755,250	712,500
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Larson Tina Marriott	President and COO	Option Exercise	C	2.47	150,000	370,500	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Larson Tina Marriott	President and COO	Option Exercise	C	1.06	712,500	755,250	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Larson Tina Marriott	President and COO	Buy	J	0.00	52,500	0	52,500	0 to 52.5 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Larson Tina Marriott	President and COO	Sell	J	0.00	52,500	0	0	52.5 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Option Exercise	C	2.22	525,000	1,165,500	525,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Option Exercise	C	2.22	525,000	1,165,500	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Option Exercise	C	18.00	12,500	225,000	12,500
Apr 22 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Option Exercise	C	18.00	12,500	225,000	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Buy	C	0.00	6,250	0	6,250	0 to 6.3 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Sell	C	0.00	6,250	0	0	6.3 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Option Exercise	C	2.47	1,500,000	3,705,000	1,500,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Option Exercise	C	2.47	1,500,000	3,705,000	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Option Exercise	C	0.00	32,685	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Option Exercise	C	0.00	22,698	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Buy	J	0.00	150,000	0	150,000	0 to 150 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Sell	J	0.00	150,000	0	0	150 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Buy	J	0.00	9,317,883	0	9,317,883	0 to 9.3 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Sell	J	0.00	9,317,883	0	0	9.3 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Gibson Christopher	Chief Executive Off ...	Buy	C	0.00	55,383	0	9,317,883	9.3 M to 9.3 M (+0.60 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Doyle Ramona	Chief Medical Offic ...	Option Exercise	C	2.47	750,000	1,852,500	750,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Doyle Ramona	Chief Medical Offic ...	Option Exercise	C	2.47	750,000	1,852,500	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Option Exercise	C	18.00	12,500	225,000	12,500
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Option Exercise	C	18.00	12,500	225,000	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Option Exercise	C	0.00	544,743	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Option Exercise	C	0.00	378,309	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Buy	C	0.00	7,688,356	0	7,688,356	0 to 7.7 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Sell	C	0.00	7,688,356	0	0	7.7 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Buy	C	0.00	923,052	0	7,688,356	6.8 M to 7.7 M (+13.64 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Option Exercise	C	0.00	3,726,963	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Option Exercise	C	0.00	730,353	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Option Exercise	C	0.00	1,095,529	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Option Exercise	C	0.00	3,220,788	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Option Exercise	C	0.00	1,073,595	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Option Exercise	C	0.00	3,771,996	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Buy	J	0.00	3,726,963	0	3,726,963	0 to 3.7 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Sell	J	0.00	3,726,963	0	0	3.7 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Buy	C	0.00	3,726,963	0	3,726,963	0 to 3.7 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Buy	J	0.00	3,951,141	0	3,951,141	0 to 4 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Sell	J	0.00	3,951,141	0	0	4 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Buy	C	0.00	3,951,141	0	3,951,141	0 to 4 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Buy	J	0.00	5,941,120	0	5,941,120	0 to 5.9 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Sell	J	0.00	5,941,120	0	0	5.9 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Data Collective IV, L.P.	10% Owner	Buy	C	0.00	5,941,120	0	5,941,120	0 to 5.9 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Option Exercise	C	2.22	525,000	1,165,500	525,000
Apr 22 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Option Exercise	C	2.22	525,000	1,165,500	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Option Exercise	C	18.00	12,500	225,000	12,500
Apr 22 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Option Exercise	C	18.00	12,500	225,000	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Buy	C	0.00	6,250	0	6,250	0 to 6.3 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Sell	C	0.00	6,250	0	0	6.3 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Option Exercise	C	2.22	404,688	898,407	404,688
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Option Exercise	C	2.22	404,688	898,407	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Option Exercise	C	18.00	12,500	225,000	12,500
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Option Exercise	C	18.00	12,500	225,000	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Buy	C	0.00	6,250	0	132,811	126.6 K to 132.8 K (+4.94 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Sell	C	0.00	6,250	0	0	6.3 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Buy	J	0.00	126,561	0	126,561	0 to 126.6 K
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Sell	J	0.00	126,561	0	0	126.6 K to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Option Exercise	C	0.00	3,726,963	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Option Exercise	C	0.00	730,353	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Option Exercise	C	0.00	1,095,529	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Option Exercise	C	0.00	3,220,788	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Option Exercise	C	0.00	1,073,595	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Option Exercise	C	0.00	3,771,996	0	0
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Buy	J	0.00	3,726,963	0	3,726,963	0 to 3.7 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Sell	J	0.00	3,726,963	0	0	3.7 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Buy	C	0.00	3,726,963	0	3,726,963	0 to 3.7 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Buy	J	0.00	3,951,141	0	3,951,141	0 to 4 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Sell	J	0.00	3,951,141	0	0	4 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Buy	C	0.00	3,951,141	0	3,951,141	0 to 4 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Buy	J	0.00	5,941,120	0	5,941,120	0 to 5.9 M
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Sell	J	0.00	5,941,120	0	0	5.9 M to 0 (-100.00 %)
Apr 22 2021	RXRX	RECURSION PHARMACE ...	Bogue Zachary	Director	Buy	C	0.00	5,941,120	0	5,941,120	0 to 5.9 M
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	1,490,783	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	1,825,883	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	3,578,653	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	10,279,275	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Buy	C	0.00	17,187,095	0	17,287,095	100 K to 17.3 M (+17,187.10 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Sell	C	0.00	17,187,095	0	0	17.2 M to 0 (-100.00 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Buy	C	0.00	17,174,594	0	17,187,095	12.5 K to 17.2 M (+137,385.76 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Buy	P	18.00	100,000	1,800,000	100,000	0 to 100 K
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	1,490,783	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	1,825,883	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	3,578,653	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Option Exercise	C	0.00	10,279,275	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Buy	C	0.00	17,187,095	0	17,287,095	100 K to 17.3 M (+17,187.10 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Sell	C	0.00	17,187,095	0	0	17.2 M to 0 (-100.00 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Buy	C	0.00	17,174,594	0	17,187,095	12.5 K to 17.2 M (+137,385.76 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Lux Ventures IV, L.P.	10% Owner	Buy	P	18.00	100,000	1,800,000	100,000	0 to 100 K
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Option Exercise	C	0.00	5,963,140	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Option Exercise	C	0.00	745,392	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Option Exercise	C	0.00	2,307,475	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Option Exercise	C	0.00	3,578,653	0	0
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Buy	C	0.00	5,963,140	0	8,740,917	2.8 M to 8.7 M (+214.67 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Buy	P	18.00	2,777,777	49,999,986	2,777,777	0 to 2.8 M
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Buy	C	0.00	745,392	0	7,062,869	6.3 M to 7.1 M (+11.80 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Buy	C	0.00	2,738,824	0	6,317,477	3.6 M to 6.3 M (+76.53 %)
Apr 20 2021	RXRX	RECURSION PHARMACE ...	Mubadala Investment Co PJSC	10% Owner	Buy	C	0.00	3,578,653	0	3,578,653	0 to 3.6 M
Apr 19 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Option Exercise	A	18.00	27,778	500,004	27,778
Apr 19 2021	RXRX	RECURSION PHARMACE ...	Li Dean Y	Director	Grant	A	0.00	13,889	0	596,390	582.5 K to 596.4 K (+2.38 %)
Apr 19 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Option Exercise	A	18.00	12,500	225,000	12,500
Apr 19 2021	RXRX	RECURSION PHARMACE ...	HERSHBERG ROBERT	Director	Grant	A	0.00	6,250	0	6,250	0 to 6.3 K
Apr 19 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Option Exercise	A	18.00	12,500	225,000	12,500
Apr 19 2021	RXRX	RECURSION PHARMACE ...	CHAVEZ R. MARTIN	Director	Grant	A	0.00	6,250	0	6,250	0 to 6.3 K
Apr 19 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Option Exercise	A	18.00	12,500	225,000	12,500
Apr 19 2021	RXRX	RECURSION PHARMACE ...	Burrell Terry-Ann	Director	Grant	A	0.00	6,250	0	126,561	120.3 K to 126.6 K (+5.19 %)
Apr 19 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Option Exercise	A	18.00	12,500	225,000	12,500
Apr 19 2021	RXRX	RECURSION PHARMACE ...	Borgeson Blake	Director	Grant	A	0.00	6,250	0	6,765,304	6.8 M to 6.8 M (+0.09 %)

Page: 1